• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

What Are Some Risk Factors for Cerebral Palsy?
Discussion The term, cerebral palsy, or CP has gone through many iterations with the first description in 1861 by W.J. Little who described it as “The condition of spastic rigidity of the limbs of newborn children.” The most recent definition is from Rosenbaun et al. in 2007 which states it is “a group of permanent disorders of the development of movement and posture, causing activity limitation, that are attributed to non-progressive disturbances that occurred in the developing fetal or infant brain. The motor disorders of cerebral palsy are often accompanied by disturbances of sensation, perception, cog...
Source: PediatricEducation.org - March 9, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Pisa-Like Syndrome Under Baclofen in a Patient With Spastic Hemiparesis due to Ischemic Stroke
Abstract: In its original description, Pisa syndrome was reported as an iatrogenic dystonia of the trunk caused by neuroleptic drugs. However, sometimes, not dystonic lateral flexion of the trunk is described as Pisa syndrome. These observations support the possibility of a drug-induced lateral flexion of the trunk with clinical presentation similar to Pisa syndrome, although with a different etiology and pathophysiology. Here, we describe the case of a male patient, with a previous ischemic stroke and residual spastic hemiparesis to the right side, who subacutely developed a dramatic lateral flexion of trunk (approximatel...
Source: Clinical Neuropharmacology - September 1, 2015 Category: Neurology Tags: Case Reports Source Type: research

Evaluation of a clinician worn device for the quantitative assessment of abnormal muscle tone type and severity (P5.178)
CONCLUSIONS: Quantitative measurements of abnormal muscle tone from a clinician worn device can distinguish type and severity of abnormal muscle tone. This device could improve assessment outcome measures, leading to improved clinical care and better evaluation of interventions for individuals with abnormal muscle tone. Study Supported by: National Institutes of Health National Institute of Neurological Disorders and Stroke (1R43NS076052-01A1).Disclosure: Dr. Brokaw has received personal compensation for activities with Great Lakes NeuroTechnologies as an employee. Dr. Itin has nothing to disclose. Dr. Heldman has received...
Source: Neurology - April 8, 2015 Category: Neurology Authors: Brokaw, E., Itin, I., Heldman, D., Giuffrida, J., Montgomery, E. Tags: Neuro-rehabilitation: Stroke Source Type: research

Drugs used to treat joint and muscle disease
Publication date: Available online 19 February 2015 Source:Anaesthesia & Intensive Care Medicine Author(s): David G. Lambert Joint disease: Arthritis can be simply broken into osteoarthritis and rheumatoid arthritis (RA). Osteoarthritis is treated with symptomatic pain relief and surgery. RA is a chronic autoimmune disease that causes inflammation of joints (leading to their destruction), tissues around joints and other organ systems. Treatment (for pain) of RA in the first instance is with non-steroidal anti-inflammatory drugs, with second-line treatment using disease-modifying antirheumatic drugs (DMARDs). DMAR...
Source: Anaesthesia and intensive care medicine - February 24, 2015 Category: Anesthesiology Source Type: research